Justin Fengler, the Chief Financial Officer of GoodRx Holdings, Inc., has reported several transactions involving the company's Class A common stock in a recent SEC filing. The transactions, which occurred on November 15, 2026, indicate Fengler's ongoing investment in the company and may influence investor sentiment.
GoodRx Holdings, Inc. operates in the services sector, specifically in computer processing and data preparation. The company is listed under the ticker GDRX and is incorporated in Delaware. The recent filing is part of a series of reports that Fengler has submitted, with the latest being filed on November 16, 2026.
According to the filing, Fengler engaged in multiple transactions involving the acquisition of shares. Notably, he acquired 6,424 shares through a transaction coded as 'M' and 28,803 shares through transactions coded as 'F', with a price of $3.56 per share for some of the transactions. Following these transactions, his total ownership increased significantly, bringing his shareholding to over 174,000 shares.
The filing also indicates that these transactions were all direct ownership, reflecting Fengler's personal stake in GoodRx. The actions taken by Fengler could affect not only his standing within the company but also investor confidence in GoodRx's future performance.
As for what comes next, the filing does not specify any further actions or upcoming events related to these transactions.
Read Next
Elmiger Eugen J Sells Shares in Monolithic Power Systems
Brahmy Dan Receives 4.1 Million RSUs as Cyabra CEO
Cyabra Grants 600,000 RSUs to CTO Shraga Ido
Heymann Emmanuel awarded 1 million RSUs at Cyabra, Inc.
Flanagan James Francis awarded 390,000 RSUs from Cyabra, Inc.
Cyabra Grants 390,000 RSUs to Director Michael P. Madon










